Also, an elevated level of Bcl-2 mRNA was found in 77% of ALL patients and 41% of AML patients, while the expression of BAX mRNA was observed only in 46% of ALL samples and 22% of AML samples. The gene discussed is BAX; the disease is acute lymphoblastic leukemia.